Literature DB >> 25803305

APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.

Janina Krell-Roesch1, Bryan K Woodruff1, Jazmin I Acosta1, Dona E Locke1, Joseph G Hentz1, Cynthia M Stonnington1, Gorazd B Stokin1, Chelsea Nagle1, Bernard F Michel1, Nathalie Sambuchi1, Richard J Caselli1, Yonas E Geda1.   

Abstract

The authors compared the risk for subjective cognitive impairment (SCI) between carriers of the apolipoprotein E ε4 (APOE ε4) allele (cases) and APOE ε4 noncarriers (controls). SCI was assessed by a validated self-reported questionnaire. The authors used multivariable logistic regression analyses to compute odds ratios and 95% confidence intervals adjusted for age, sex, education, and marital status. Data were available on 114 participants (83 women; 47 APOE ε4 carriers; mean age, 69 years). The risk for SCI was significantly higher among cases than controls, particularly for those 70 years of age and older. These findings should be considered preliminary until confirmed by a prospective cohort study.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25803305      PMCID: PMC4581892          DOI: 10.1176/appi.neuropsych.14100268

Source DB:  PubMed          Journal:  J Neuropsychiatry Clin Neurosci        ISSN: 0895-0172            Impact factor:   2.198


  36 in total

1.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Specific subjective memory complaints in older persons may indicate poor cognitive function.

Authors:  Rebecca England Amariglio; Mary K Townsend; Francine Grodstein; Reisa A Sperling; Dorene M Rentz
Journal:  J Am Geriatr Soc       Date:  2011-09-15       Impact factor: 5.562

Review 3.  Apolipoprotein E alleles as risk factors in Alzheimer's disease.

Authors:  A D Roses
Journal:  Annu Rev Med       Date:  1996       Impact factor: 13.739

4.  Memory Functioning Questionnaire: concurrent validity with memory performance and self-reported memory failures.

Authors:  Elizabeth M Zelinski; Michael J Gilewski; Cheri R Anthony-Bergstone
Journal:  Psychol Aging       Date:  1990-09

5.  Subjective cognition and amyloid deposition imaging: a Pittsburgh Compound B positron emission tomography study in normal elderly individuals.

Authors:  Audrey Perrotin; Elizabeth C Mormino; Cindee M Madison; Amynta O Hayenga; William J Jagust
Journal:  Arch Neurol       Date:  2012-02

6.  The APOE epsilon4 allele is associated with incident mild cognitive impairment among community-dwelling older persons.

Authors:  Patricia A Boyle; Aron S Buchman; Robert S Wilson; Jeremiah F Kelly; David A Bennett
Journal:  Neuroepidemiology       Date:  2009-11-11       Impact factor: 3.282

7.  Longitudinal modeling of age-related memory decline and the APOE epsilon4 effect.

Authors:  Richard J Caselli; Amylou C Dueck; David Osborne; Marwan N Sabbagh; Donald J Connor; Geoffrey L Ahern; Leslie C Baxter; Steven Z Rapcsak; Jiong Shi; Bryan K Woodruff; Dona E C Locke; Charlene Hoffman Snyder; Gene E Alexander; Rosa Rademakers; Eric M Reiman
Journal:  N Engl J Med       Date:  2009-07-16       Impact factor: 91.245

8.  Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults.

Authors:  Susanne I Steinberg; Selamawit Negash; Mary D Sammel; Hillary Bogner; Brian T Harel; Melissa G Livney; Hannah McCoubrey; David A Wolk; Mitchel A Kling; Steven E Arnold
Journal:  Am J Alzheimers Dis Other Demen       Date:  2013-12       Impact factor: 2.035

9.  Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.

Authors:  Pieter Jelle Visser; Frans Verhey; Dirk L Knol; Philip Scheltens; Lars-Olof Wahlund; Yvonne Freund-Levi; Magda Tsolaki; Lennart Minthon; Asa K Wallin; Harald Hampel; Katharina Bürger; Tuula Pirttila; Hilkka Soininen; Marcel Olde Rikkert; Marcel M Verbeek; Luiza Spiru; Kaj Blennow
Journal:  Lancet Neurol       Date:  2009-06-10       Impact factor: 44.182

10.  Revising the definition of Alzheimer's disease: a new lexicon.

Authors:  Bruno Dubois; Howard H Feldman; Claudia Jacova; Jeffrey L Cummings; Steven T Dekosky; Pascale Barberger-Gateau; André Delacourte; Giovanni Frisoni; Nick C Fox; Douglas Galasko; Serge Gauthier; Harald Hampel; Gregory A Jicha; Kenichi Meguro; John O'Brien; Florence Pasquier; Philippe Robert; Martin Rossor; Steven Salloway; Marie Sarazin; Leonardo C de Souza; Yaakov Stern; Pieter J Visser; Philip Scheltens
Journal:  Lancet Neurol       Date:  2010-10-09       Impact factor: 44.182

View more
  4 in total

1.  Subjective cognitive decline, APOE e4 allele, and the risk of neurocognitive disorders: Age- and sex-stratified cohort study.

Authors:  Tau Ming Liew
Journal:  Aust N Z J Psychiatry       Date:  2022-03-01       Impact factor: 5.598

Review 2.  The role of APOE in cerebrovascular dysfunction.

Authors:  Leon M Tai; Riya Thomas; Felecia M Marottoli; Kevin P Koster; Takahisa Kanekiyo; Alan W J Morris; Guojun Bu
Journal:  Acta Neuropathol       Date:  2016-02-16       Impact factor: 17.088

3.  No association between APOE genotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab.

Authors:  Laura E Korthauer; Robert P Giugliano; Jianping Guo; Marc S Sabatine; Peter Sever; Anthony Keech; Dan Atar; Christopher Kurtz; Christian T Ruff; Francois Mach; Brian R Ott
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

4.  Subjective cognitive decline and risk of MCI: The Mayo Clinic Study of Aging.

Authors:  Argonde C van Harten; Michelle M Mielke; Dana M Swenson-Dravis; Clinton E Hagen; Kelly K Edwards; Rosebud O Roberts; Yonas E Geda; David S Knopman; Ronald C Petersen
Journal:  Neurology       Date:  2018-06-29       Impact factor: 11.800

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.